How to Source Dordaviprone hydrochloride for Pharmaceutical Formulation

Dordaviprone hydrochloride (Capsules, 125 mg) is classified under Oncology Cancer Care. It is therapeutically aligned with reference brands such as Modeyso (USA). This guide highlights key sourcing factors buyers should consider when procuring high-quality Dordaviprone hydrochloride for formulation, R&D, or bulk manufacturing.

Product Overview: Dordaviprone (Modeyso) is a novel targeted anticancer medication used to treat diffuse midline glioma with an H3 K27M mutation in adults and children aged 1 year and older. It works by activating mitochondrial protease ClpP and inhibiting dopamine D2 receptors to disrupt tumor growth. This drug is orally administered once weekly as a capsule. It received accelerated FDA approval in 2025 for patients whose disease has progressed after prior therapy. The therapy represents the first systemic option for this rare and aggressive brain tumor.

Dordaviprone hydrochloride API in Capsules form, 125 mg specification
Dordaviprone hydrochloride API – ideal for compliant pharmaceutical formulation.
Quick Insight: Over 60% of formulation delays are linked to poor API sourcing. A well-planned sourcing strategy can reduce risk and accelerate market entry.

1. Regulatory Compliance & Documentation

Ensure suppliers provide:

2. Purity, Grade & Specification Matching

Dordaviprone hydrochloride must meet exact grade and purity for your dosage form:

3. Supplier Reliability & Audit History

4. Commercial Terms: Pricing, MOQ & Flexibility

5. Lead Time, Inventory & Logistics

Typical lead time for Dordaviprone hydrochloride is 4–6 weeks.

6. Formulation Support

Pro Tip: Engage supplier formulation experts early — it can improve bioavailability and cut development time.

Conclusion

Sourcing Dordaviprone hydrochloride is more than procurement—it’s a strategic partnership. With its capsules form and 125 mg specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.

Next Step: Get expert assistance in sourcing Dordaviprone hydrochloride.

Request a Quote

Frequently Asked Questions For Sourcing of Dordaviprone hydrochloride

What is the typical lead time for Dordaviprone hydrochloride?

Lead times range from 4–6 weeks depending on supplier and region.

Is Dordaviprone hydrochloride available in multiple grades?

Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.

Does Dordaviprone hydrochloride require special storage?

It should be stored in a cool, dry place away from direct sunlight.

Is a Drug Master File (DMF) available for Dordaviprone hydrochloride?

Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.

Can I request samples or a pilot batch of Dordaviprone hydrochloride?

Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.

What compliance certificates are available for Dordaviprone hydrochloride?

Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.

Is Dordaviprone hydrochloride suitable for regulated markets like US/EU?

Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.

Can Dordaviprone hydrochloride be used in fixed-dose combinations?

Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.